Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy
Clinical trial NCT04628585 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04628585
- Sponsor
- Genetix Biotherapeutics Inc.
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-21
- Primary completion
- 2038-01-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.